Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06544564 · ClinicalTrials.gov registry record · NA
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
A NA study of Venous Leg Ulcer, sponsored by BioLab Holdings.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 9
- Study locations
NCT06544564: Recruiting NA study of Venous Leg Ulcer, sponsored by BioLab Holdings.
NCT06544564 is a NA study of Venous Leg Ulcer that is actively recruiting participants, run by BioLab Holdings. The registered enrollment target is 150 participants, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (38% lower). The trial reports 9 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06544564, a NA study of Venous Leg Ulcer, is actively recruiting participants, sponsored by BioLab Holdings.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 9
- Study locations
Study Summary
This study is designed to assess the clinical effectiveness of Membrane Wrap, a human amniotic membrane for the management of difficult to heal partial- or full-thickness venous leg ulcers (VLUs)
Primary Outcome
Wound Closure is defined as: * Full epithelialization of the wound with the absence of drainage * Epithelialization is defined as a layer of epithelium visible on the wound surface
Conditions Studied
Interventions
- OTHER Standard of Care
- DEVICE Membrane Wrap™
Study Locations (9)
Florida
- Midland Florida Clinical Research Center - DeLand
- Biophase Research - North Miami Beach
- Doctors Research Network - South Miami
Arizona
- Tital Clinical Research - Mesa
California
- Center for Clinical Research - San Francisco
Illinois
- Gateway Clinical Trials - O'Fallon
New York
- Northwell Health - Lake Success
Ohio
- Kent State College of Podiatry - Cleveland
Texas
- Advantage Foot Care of Houston - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2025-03-31 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What NCT06544564 shows while recruiting
NCT06544564 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (38% lower).
The record links to 1 condition, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.
NCT06544564 lists 9 locations in 7 states (Florida, Arizona, California).
Frequently Asked Questions
What is clinical trial NCT06544564 about?
NCT06544564 is a clinical study titled "Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population". This study is designed to assess the clinical effectiveness of Membrane Wrap, a human amniotic membrane for the management of difficult to heal partial- or full-thickness venous leg ulcers (VLUs)
What is the current status of trial NCT06544564?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-03-31. Estimated completion is 2026-09-30.
What conditions does trial NCT06544564 study?
This clinical trial studies the following conditions: Venous Leg Ulcer.
What interventions are being tested in trial NCT06544564?
The interventions under investigation include: Standard of Care (OTHER), Membrane Wrap™ (DEVICE).
Who is sponsoring clinical trial NCT06544564?
This trial is sponsored by BioLab Holdings, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06544564 being conducted?
This trial has 9 study locations across Arizona, California, Florida, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06544564's enrollment target sits among peer trials
150 17th of 35 higher than 18 of 35 other Venous Leg Ulcer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Leg Ulcer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center
RECRUITING · NA
-
INNOVEN: Efficacy of Porcine Placental Extracellular Matrix Plus Standard of Care (SOC) Versus SOC Alone
RECRUITING · NA
-
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
RECRUITING · NA
-
Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers Using Near Infrared Laser Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI